BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 90177)

  • 1. Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia.
    Bartsch G; Müller HR; Oberholzer M; Rohr HP
    J Urol; 1979 Oct; 122(4):487-91. PubMed ID: 90177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electron microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia.
    Bartsch G; Frick J; Rüegg I; Bucher M; Holliger O; Oberholzer M; Rohr HP
    J Urol; 1979 Oct; 122(4):481-6. PubMed ID: 90176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative light and electron microscopic study of the human, dog and rat prostate. An approach to an experimental model for human benign prostatic hyperplasia (light and electron microscopic analysis)--a review.
    Bartsch G; Rohr HP
    Urol Int; 1980; 35(2):91-104. PubMed ID: 6154990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereology, a new quantitative morphological approach to study prostatic function and disease.
    Bartsch G
    Eur Urol; 1977; 3(2):85-95. PubMed ID: 67949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light-microscopic stereologic analysis of spontaneous and steroid-induced canine prostatic hyperplasia.
    Bartsch G; Bruengger A; de Klerk DP; Coffey DS; Rohr HP
    J Urol; 1987 Mar; 137(3):552-8. PubMed ID: 2434668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of biochemical (receptors, endogenous tissue hormones) and quantitative morphologic (stereologic) findings in normal and hyperplastic human prostates.
    Bartsch G; Keen F; Daxenbichler G; Marth C; Margreiter R; Brüngger A; Sutter T; Rohr HP
    J Urol; 1987 Mar; 137(3):559-64. PubMed ID: 2434669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia.
    Marks LS; Partin AW; Gormley GJ; Dorey FJ; Shery ED; Garris JB; Subong EN; Stoner E; deKernion JB
    J Urol; 1997 Jun; 157(6):2171-8. PubMed ID: 9146609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma.
    Hussein MR; Al-Assiri M; Musalam AO
    Exp Mol Pathol; 2009 Apr; 86(2):108-13. PubMed ID: 19111537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric evaluation of benign prostatic hyperplasia.
    Siegel YI; Zaidel L; Hammel I; Korczak D; Lindner A
    Eur Urol; 1990; 18(1):71-3. PubMed ID: 1698158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using transrectal 31phosphorus magnetic resonance spectroscopy: a preliminary report.
    Narayan P; Jajodia P; Kurhanewicz J; Thomas A; MacDonald J; Hubesch B; Hedgcock M; Anderson CM; James TL; Tanagho EA
    J Urol; 1991 Jul; 146(1):66-74. PubMed ID: 1711587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New histopathological experimental model for benign prostatic hyperplasia: stromal hyperplasia in rats.
    Mori F; Oda N; Sakuragi M; Sakakibara F; Kiniwa M; Miyoshi K
    J Urol; 2009 Feb; 181(2):890-8. PubMed ID: 19095262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metachromasia in the human prostate: a histochemical difference between benign prostatic hyperplasia and prostatic carcinoma.
    Arcadi JA
    J Urol; 1988 Feb; 139(2):315-7. PubMed ID: 2448498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytological atypia in the prostate gland: frequency, distribution and possible relevance to carcinoma.
    Oyasu R; Bahnson RR; Nowels K; Garnett JE
    J Urol; 1986 May; 135(5):959-62. PubMed ID: 2421020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal histology of the prostate.
    McNeal JE
    Am J Surg Pathol; 1988 Aug; 12(8):619-33. PubMed ID: 2456702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereological evaluation of fibronectin in the periurethral region of the transitional zone from normal human prostates compared with benign prostatic hyperplasia.
    Manaia JH; Cardoso GP; Babinski MA
    Int J Clin Exp Pathol; 2015; 8(4):4143-7. PubMed ID: 26097605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ezetimibe reduces enlarged prostate in an animal model of benign prostatic hyperplasia.
    Pelton K; Di Vizio D; Insabato L; Schaffner CP; Freeman MR; Solomon KR
    J Urol; 2010 Oct; 184(4):1555-9. PubMed ID: 20728125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transrectal prostatic ultrasonography. Equipment, normal findings, benign hyperplasia and cancer.
    Torp-Pedersen S; Juul N; Jakobsen H
    Scand J Urol Nephrol Suppl; 1988; 107():19-25. PubMed ID: 2453918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative histopathologic and sonomorphological prostate studies].
    Egender G; Rapf C; Feichtinger I; Mikuz G; Bartsch G; Frommhold H
    Rofo; 1984 Jan; 140(1):60-6. PubMed ID: 6198266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
    Tan AH; Gilling PJ; Kennett KM; Frampton C; Westenberg AM; Fraundorfer MR
    J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma.
    Mazzucchelli L; Loetscher P; Kappeler A; Uguccioni M; Baggiolini M; Laissue JA; Mueller C
    Am J Pathol; 1996 Aug; 149(2):501-9. PubMed ID: 8701989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.